Literature DB >> 1714377

Signal transduction by normal isoforms and W mutant variants of the Kit receptor tyrosine kinase.

A D Reith1, C Ellis, S D Lyman, D M Anderson, D E Williams, A Bernstein, T Pawson.   

Abstract

Germline mutations at the Dominant White Spotting (W) and Steel (Sl) loci have provided conclusive genetic evidence that c-kit mediated signal transduction pathways are essential for normal mouse development. We have analysed the interactions of normal and mutant W/c-kit gene products with cytoplasmic signalling proteins, using transient c-kit expression assays in COS cells. In addition to the previously identified c-kit gene product (Kit+), a second normal Kit isoform (KitA+) containing an in-frame insertion, Gly-Asn-Asn-Lys, within the extracellular domain, was detected in murine mast cell cultures and mid-gestation placenta. Both Kit+ and KitA+ isoforms showed increased autophosphorylation and enhanced association with phosphatidylinositol (PI) 3' kinase and PLC gamma 1, when stimulated with recombinant soluble Steel factor. No association or increase in phosphorylation of GAP and two GAP-associated proteins, p62 and p190, was observed. The two isoforms had distinct activities in the absence of exogenous soluble Steel factor; Kit+, but not KitA+, showed constitutive tyrosine phosphorylation that was accompanied by a low constitutive level of association with PI-3' kinase and PLC gamma 1. Introduction of the point substitutions associated with W37 (Glu582----Lys) or W41 (Val831----Met) mutant alleles into c-kit expression constructs abolished (W37) or reduced (W41) the Steel factor-induced association of the Kit receptor with signalling proteins in a manner proportional to the overall severity of the corresponding W mutant phenotype. These data suggest a diversity of normal Kit signalling pathways and indicate that W mutant phenotypes result from primary defects in the Kit receptor that affect its interaction with cytoplasmic signalling proteins.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1714377      PMCID: PMC452940          DOI: 10.1002/j.1460-2075.1991.tb07784.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  83 in total

1.  Common elements in growth factor stimulation and oncogenic transformation: 85 kd phosphoprotein and phosphatidylinositol kinase activity.

Authors:  D R Kaplan; M Whitman; B Schaffhausen; D C Pallas; M White; L Cantley; T M Roberts
Journal:  Cell       Date:  1987-09-25       Impact factor: 41.582

2.  The myristylation signal of p60v-src functionally complements the N-terminal fps-specific region of P130gag-fps.

Authors:  A R Brooks-Wilson; E Ball; T Pawson
Journal:  Mol Cell Biol       Date:  1989-05       Impact factor: 4.272

3.  Replacement of insulin receptor tyrosine residues 1162 and 1163 compromises insulin-stimulated kinase activity and uptake of 2-deoxyglucose.

Authors:  L Ellis; E Clauser; D O Morgan; M Edery; R A Roth; W J Rutter
Journal:  Cell       Date:  1986-06-06       Impact factor: 41.582

4.  The proto-oncogene c-kit encoding a transmembrane tyrosine kinase receptor maps to the mouse W locus.

Authors:  B Chabot; D A Stephenson; V M Chapman; P Besmer; A Bernstein
Journal:  Nature       Date:  1988-09-01       Impact factor: 49.962

5.  The dominant-white spotting (W) locus of the mouse encodes the c-kit proto-oncogene.

Authors:  E N Geissler; M A Ryan; D E Housman
Journal:  Cell       Date:  1988-10-07       Impact factor: 41.582

6.  Type I phosphatidylinositol kinase makes a novel inositol phospholipid, phosphatidylinositol-3-phosphate.

Authors:  M Whitman; C P Downes; M Keeler; T Keller; L Cantley
Journal:  Nature       Date:  1988-04-14       Impact factor: 49.962

Review 7.  Growth factor superfamilies and mammalian embryogenesis.

Authors:  M Mercola; C D Stiles
Journal:  Development       Date:  1988-03       Impact factor: 6.868

8.  Human proto-oncogene c-kit: a new cell surface receptor tyrosine kinase for an unidentified ligand.

Authors:  Y Yarden; W J Kuang; T Yang-Feng; L Coussens; S Munemitsu; T J Dull; E Chen; J Schlessinger; U Francke; A Ullrich
Journal:  EMBO J       Date:  1987-11       Impact factor: 11.598

9.  Primary structure of c-kit: relationship with the CSF-1/PDGF receptor kinase family--oncogenic activation of v-kit involves deletion of extracellular domain and C terminus.

Authors:  F H Qiu; P Ray; K Brown; P E Barker; S Jhanwar; F H Ruddle; P Besmer
Journal:  EMBO J       Date:  1988-04       Impact factor: 11.598

10.  Expression of the FGF-related proto-oncogene int-2 during gastrulation and neurulation in the mouse.

Authors:  D G Wilkinson; G Peters; C Dickson; A P McMahon
Journal:  EMBO J       Date:  1988-03       Impact factor: 11.598

View more
  51 in total

Review 1.  Targeting KIT in melanoma: a paradigm of molecular medicine and targeted therapeutics.

Authors:  Scott E Woodman; Michael A Davies
Journal:  Biochem Pharmacol       Date:  2010-05-08       Impact factor: 5.858

2.  Heterozygous kit mutants with little or no apparent anemia exhibit large defects in overall hematopoietic stem cell function.

Authors:  Yashoda Sharma; Clinton M Astle; David E Harrison
Journal:  Exp Hematol       Date:  2007-02       Impact factor: 3.084

3.  Two members of the thioredoxin-h family interact with the kinase domain of a Brassica S locus receptor kinase.

Authors:  M S Bower; D D Matias; E Fernandes-Carvalho; M Mazzurco; T Gu; S J Rothstein; D R Goring
Journal:  Plant Cell       Date:  1996-09       Impact factor: 11.277

4.  SHP-1 binds and negatively modulates the c-Kit receptor by interaction with tyrosine 569 in the c-Kit juxtamembrane domain.

Authors:  M Kozlowski; L Larose; F Lee; D M Le; R Rottapel; K A Siminovitch
Journal:  Mol Cell Biol       Date:  1998-04       Impact factor: 4.272

5.  Small Molecule Amyloid-β Protein Precursor Processing Modulators Lower Amyloid-β Peptide Levels via cKit Signaling.

Authors:  Ci-Di Chen; Ella Zeldich; Christina Khodr; Kaddy Camara; Tze Yu Tung; Emma C Lauder; Patrick Mullen; Taryn J Polanco; Yen-Yu Liu; Dean Zeldich; Weiming Xia; William E Van Nostrand; Lauren E Brown; John A Porco; Carmela R Abraham
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

Review 6.  Molecular basis of functional myogenic specification of Bona Fide multipotent adult cardiac stem cells.

Authors:  Eleonora Cianflone; Iolanda Aquila; Mariangela Scalise; Pina Marotta; Michele Torella; Bernardo Nadal-Ginard; Daniele Torella
Journal:  Cell Cycle       Date:  2018-06-25       Impact factor: 4.534

7.  The v-Src SH3 domain binds phosphatidylinositol 3'-kinase.

Authors:  X Liu; L E Marengere; C A Koch; T Pawson
Journal:  Mol Cell Biol       Date:  1993-09       Impact factor: 4.272

8.  Kit signaling through PI 3-kinase and Src kinase pathways: an essential role for Rac1 and JNK activation in mast cell proliferation.

Authors:  I Timokhina; H Kissel; G Stella; P Besmer
Journal:  EMBO J       Date:  1998-11-02       Impact factor: 11.598

9.  The meaning of the c-kit proto-oncogene product in malignant transformation in human mammary epithelium.

Authors:  Chang Dae Ko; Jee Soo Kim; Byung Gyun Ko; Byung Ho Son; Hee Joon Kang; Ho Sung Yoon; Eun Yoon Cho; Gyungyub Gong; Sei Hyun Ahn
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

10.  Detection of novel polymorphisms in the ckit gene of canine patients with lymphoma, melanoma, haemangiosarcoma, and osteosarcoma.

Authors:  Irina Gramer; Martin Kessler; Joachim Geyer
Journal:  Vet Res Commun       Date:  2016-03-12       Impact factor: 2.459

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.